These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8942984)
1. PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins. Bailly C; Payet D; Travers AA; Waring MJ Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13623-8. PubMed ID: 8942984 [TBL] [Abstract][Full Text] [Related]
2. Footprinting of echinomycin and actinomycin D on DNA molecules asymmetrically substituted with inosine and/or 2,6-diaminopurine. Jennewein S; Waring MJ Nucleic Acids Res; 1997 Apr; 25(8):1502-10. PubMed ID: 9092655 [TBL] [Abstract][Full Text] [Related]
3. The influence of the exocyclic amino group characteristic of GC base pairs on molecular recognition of specific nucleotide sequences in DNA by berenil and DAPI. Waring MJ; Bailly C J Mol Recognit; 1997; 10(3):121-7. PubMed ID: 9408827 [TBL] [Abstract][Full Text] [Related]
4. The use of diaminopurine to investigate structural properties of nucleic acids and molecular recognition between ligands and DNA. Bailly C; Waring MJ Nucleic Acids Res; 1998 Oct; 26(19):4309-14. PubMed ID: 9742229 [TBL] [Abstract][Full Text] [Related]
5. Dissecting direct and indirect readout of cAMP receptor protein DNA binding using an inosine and 2,6-diaminopurine in vitro selection system. Lindemose S; Nielsen PE; Møllegaard NE Nucleic Acids Res; 2008 Aug; 36(14):4797-807. PubMed ID: 18653536 [TBL] [Abstract][Full Text] [Related]
7. Netropsin, distamycin and berenil interact differentially with a high-affinity binding site for the high mobility group protein HMG-I. Wegner M; Grummt F Biochem Biophys Res Commun; 1990 Feb; 166(3):1110-7. PubMed ID: 2154972 [TBL] [Abstract][Full Text] [Related]
8. DNase I footprinting of triple helix formation at polypurine tracts by acridine-linked oligopyrimidines: stringency, structural changes and interaction with minor groove binding ligands. Stonehouse TJ; Fox KR Biochim Biophys Acta; 1994 Aug; 1218(3):322-30. PubMed ID: 8049258 [TBL] [Abstract][Full Text] [Related]
9. Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions. Passadore M; Feriotto G; Bianchi N; Aguiari G; Mischiati C; Piva R; Gambari R J Biochem Biophys Methods; 1994 Dec; 29(3-4):307-19. PubMed ID: 7699207 [TBL] [Abstract][Full Text] [Related]
10. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter. Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565 [TBL] [Abstract][Full Text] [Related]
11. Transferring the purine 2-amino group from guanines to adenines in DNA changes the sequence-specific binding of antibiotics. Bailly C; Waring MJ Nucleic Acids Res; 1995 Mar; 23(6):885-92. PubMed ID: 7731800 [TBL] [Abstract][Full Text] [Related]
12. Investigations into the sequence-selective binding of mithramycin and related ligands to DNA. Fox KR; Howarth NR Nucleic Acids Res; 1985 Dec; 13(24):8695-714. PubMed ID: 2934687 [TBL] [Abstract][Full Text] [Related]
13. Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. Sastry M; Fiala R; Patel DJ J Mol Biol; 1995 Sep; 251(5):674-89. PubMed ID: 7666419 [TBL] [Abstract][Full Text] [Related]
14. DNA recognition by quinoline antibiotics: use of base-modified DNA molecules to investigate determinants of sequence-specific binding of luzopeptin. Bailly C; Crow S; Minnock A; Waring MJ Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1337-53. PubMed ID: 11097063 [TBL] [Abstract][Full Text] [Related]
15. Effects of base substitutions on the binding of a DNA-bending protein. Bailly C; Waring MJ; Travers AA J Mol Biol; 1995 Oct; 253(1):1-7. PubMed ID: 7473705 [TBL] [Abstract][Full Text] [Related]
16. Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin. Vigneswaran N; Thayaparan J; Knops J; Trent J; Potaman V; Miller DM; Zacharias W Biol Chem; 2001 Feb; 382(2):329-42. PubMed ID: 11308031 [TBL] [Abstract][Full Text] [Related]
17. DNA sequence recognition by the antitumor drug ditercalinium. Crow SD; Bailly C; Garbay-Jaureguiberry C; Roques B; Shaw BR; Waring MJ Biochemistry; 2002 Jul; 41(27):8672-82. PubMed ID: 12093285 [TBL] [Abstract][Full Text] [Related]
18. The recognition of distorted DNA structures by HMG-D: a footprinting and molecular modelling study. Payet D; Hillisch A; Lowe N; Diekmann S; Travers A J Mol Biol; 1999 Nov; 294(1):79-91. PubMed ID: 10556030 [TBL] [Abstract][Full Text] [Related]
19. The RNA polymerase I transcription factor UBF is a sequence-tolerant HMG-box protein that can recognize structured nucleic acids. Copenhaver GP; Putnam CD; Denton ML; Pikaard CS Nucleic Acids Res; 1994 Jul; 22(13):2651-7. PubMed ID: 8041627 [TBL] [Abstract][Full Text] [Related]
20. High mobility group proteins HMG-1 and HMG-I/Y bind to a positive regulatory region of the pea plastocyanin gene promoter. Webster CI; Packman LC; Pwee KH; Gray JC Plant J; 1997 Apr; 11(4):703-15. PubMed ID: 9161031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]